Andhra Pradesh, India

Sureshkumar Talluri



 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Nalgonda, IN (2016)
  • Andhra Pradesh, IN (2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Sureshkumar Talluri in Pharmaceutical Research

Introduction

Sureshkumar Talluri is a notable inventor based in Andhra Pradesh, India. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds that target various diseases. With a total of three patents to his name, Talluri's work is paving the way for new therapeutic options.

Latest Patents

Among his latest patents, Talluri has developed substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors. These compounds, according to Formulas I, IA, or IB, are designed for use in pharmaceutically acceptable compositions and their salts. The synthesis and application of these compounds aim to provide treatment options for various diseases and disorders, including cancer, stroke, cardiovascular issues, obesity, and type II diabetes.

Career Highlights

Sureshkumar Talluri is currently associated with Arrien Pharmaceuticals LLC, where he continues to innovate and contribute to the pharmaceutical industry. His expertise in developing SIK2 inhibitors showcases his commitment to advancing medical science and improving patient outcomes.

Collaborations

Talluri collaborates with talented professionals in his field, including Hariprasad Vankayalapati and Venkatakrishnareddy Yerramreddy. These collaborations enhance the research and development process, leading to more effective solutions in healthcare.

Conclusion

Sureshkumar Talluri's work exemplifies the spirit of innovation in pharmaceutical research. His contributions through patents and collaborations are vital in the ongoing fight against serious health conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…